We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $85.1B
1-Year Est. Return 20.93%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$13.4B
AUM Growth
+$5.98B
Cap. Flow
+$4.58B
Cap. Flow %
34.18%
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$51.4M
2
LOW icon
Lowe's Companies
LOW
+$45.3M
3
CVS icon
CVS Health
CVS
+$37.3M
4
LLY icon
Eli Lilly
LLY
+$32.7M
5
SO icon
Southern Company
SO
+$30.6M

Sector Composition

Rank Sector Weight
1 Technology 14.47%
2 Consumer Discretionary 11.59%
3 Healthcare 8.66%
4 Financials 6.8%
5 Industrials 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AREC icon
2826
American Resources Corp
AREC
$186M
$31K ﹤0.01%
+15,903
New +$26.7K
VRN
2827
DELISTED
Veren
VRN
$31K ﹤0.01%
+13,104
New +$22.4K
LSTA icon
2828
Lisata Therapeutics
LSTA
$15.2M
$30K ﹤0.01%
+1,376
New +$32.7K
VANI icon
2829
Vivani Medical
VANI
$110M
$29K ﹤0.01%
+5,227
New +$18.5K
NYMX
2830
DELISTED
Nymox Pharmaceutical Corp
NYMX
$29K ﹤0.01%
11,816
-6,299
-35% -$13.9K
AIFA
2831
All In FutureTech Alliance Inc
AIFA
$12.2M
$28K ﹤0.01%
+2,916
New +$21K
CKPT
2832
DELISTED
Checkpoint Therapeutics
CKPT
$28K ﹤0.01%
+1,070
New +$27.1K
TK icon
2833
Teekay
TK
$975M
$26K ﹤0.01%
12,153
-14,964
-55% -$33.7K
ALNA
2834
DELISTED
Allena Pharmaceuticals
ALNA
$23K ﹤0.01%
+17,840
New +$24.9K
MRIN
2835
DELISTED
Marin Software
MRIN
$22K ﹤0.01%
+1,830
New +$22K
AVGR
2836
DELISTED
Avinger, Inc. Common Stock
AVGR
$21K ﹤0.01%
+160
New +$14.5K
ATHX
2837
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
485
-463
-49% -$21.1K
LPCN icon
2838
Lipocine
LPCN
$17.1M
$19K ﹤0.01%
+803
New +$19.3K
VERO
2839
DELISTED
Venus Concept
VERO
$18K ﹤0.01%
+64
New +$23.9K
SALM
2840
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$18K ﹤0.01%
+17,553
New +$17.8K
TLPH icon
2841
Talphera
TLPH
$70.1M
$16K ﹤0.01%
+639
New +$19.5K
MBII
2842
DELISTED
Marrone Bio Innovations, Inc.
MBII
$16K ﹤0.01%
+12,663
New +$15.1K
HURA
2843
TuHURA Biosciences
HURA
$134M
$15K ﹤0.01%
+7
New +$17.6K
CRVO icon
2844
CervoMed
CRVO
$24.6M
$14K ﹤0.01%
240
-82
-25% -$4.8K
RGLS
2845
DELISTED
Regulus Therapeutics
RGLS
$14K ﹤0.01%
+1,013
New +$7.44K
OGEN icon
2846
Oragenics
OGEN
$2.31M
$13K ﹤0.01%
+16
New +$14.1K
PULM icon
2847
Pulmatrix
PULM
$6.03M
$13K ﹤0.01%
+537
New +$12.8K
REED
2848
DELISTED
Reeds, Inc. Common Stock
REED
$13K ﹤0.01%
424
-3,019
-88% -$118K
MMAT
2849
DELISTED
Meta Materials Inc. Common Stock
MMAT
$11K ﹤0.01%
+76
New +$5.93K
MBRX icon
2850
Moleculin Biotech
MBRX
$15M
$10K ﹤0.01%
+5
New +$8.87K

Similar funds

Squarepoint's Q4 2020 Portfolio in Review

As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Squarepoint deployed $4.58B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.

  • Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
  • Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
  • Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
  • Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
  • Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
  • Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.